Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Small and emerging companies face challenges related to limited funding and resources, such as technical expertise and capacity, making it imperative they find a competent partner to support them.
Download this case study to learn why 4SC selected Thermo Fisher Scientific Pharma Services as their CDMO partner to develop its lead asset, resminostat.